Catalyst Wire Dossier Catalyst Wire Dossier

F598

· Alopexx Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F598, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males [Phase 2]

See pricing